中华护理杂志 ›› 2025, Vol. 60 ›› Issue (1): 43-46.DOI: 10.3761/j.issn.0254-1769.2025.01.006

• 标准与规范 • 上一篇    下一篇

乳腺癌靶向药物皮下注射护理专家共识

中华护理学会肿瘤护理专业委员会 上海市抗癌协会肿瘤护理专业委员会(执笔:王丽英 覃惠英 陆宇晗 裘佳佳 陆箴琦)()   

  1. 200032 上海市 复旦大学附属肿瘤医院护理部,复旦大学上海医学院肿瘤学系(王丽英,裘佳佳,陆箴琦);中山大学肿瘤防治中心护理部(覃惠英);北京大学肿瘤医院护理部(陆宇晗)
  • 收稿日期:2024-04-09 出版日期:2025-01-10 发布日期:2025-01-05
  • 作者简介:王丽英:女,硕士(博士在读),副主任护师,护士长,E-mail:ying09211170007@126.com

Expert consensus on breast cancer targeted therapy with subcutaneous injection

Cancer Nursing Committee of Chinese Nursing Association, Cancer Nursing Committee of Shanghai Anti-Cancer Association(Writing Committee:WANG Liying, QIN Huiying, LU Yuhan, QIU Jiajia, LU Zhenqi)()   

  • Received:2024-04-09 Online:2025-01-10 Published:2025-01-05

摘要:

目的 制订“乳腺癌靶向药物皮下注射护理专家共识”(以下简称“共识”),以指导临床护理实践。 方法 成立“共识”制订小组,在国内外文献回顾的基础上,形成“共识”初稿。2023年12月—2024年2月,邀请来自乳腺癌临床护理或医疗、药理、肿瘤医院护理或医疗管理等领域的84名专家进行2轮函询,并通过1次现场专家论证会及1次线上专家定稿会,形成“共识”终稿。 结果 “共识”包括药物介绍、药物皮下注射(注射人员、注射前准备、注射要点、注射后的观察与记录)、不良反应的护理、健康教育与随访等内容。 结论 “共识”具有一定的科学性和实用性,可为乳腺癌靶向药物皮下注射临床护理实践提供参考。

关键词: 曲妥珠单抗, 帕妥珠单抗, 注射, 皮下, 乳腺癌, 专家共识, 护理

Abstract:

Objective To develop an expert consensus on the subcutaneous injection of targeted drugs for breast cancer,to guide clinical nursing practice. Methods A consensus building group was established to create the initial draft of the consensus based on a review of literature. From December 2023 to February 2024,a total of 84 experts from various fields including breast cancer clinical nursing or medical practice,pharmacology,cancer hospital nursing or medical management were invited to participate in 2 rounds of expert letter consultations. Additionally,an on-site expert discussion meeting and an online expert finalization meeting were conducted to finalize the draft “consensus”. Results The finalized consensus includes sections covering basic drug introduction,drug injection nursing(injection personnel,injection preparation,injection points,observation and recording after injection),nursing care for adverse reactions,patient education and follow-up. Conclusion This consensus is scientific and practical. It can serve as a valuable reference for clinical practice related to subcutaneous therapy using targeted drugs for breast cancer.

Key words: Trastuzumab, Pertuzumab, Injections, Subcutaneous, Breast Cancer, Expert Consensus, Nursing Care